Related Experiment Video
Updated: Dec 17, 2025

Adapting Gastrointestinal Organoids for Pathogen Infection and Single Cell Sequencing under Biosafety Level 3 BSL-3 Conditions
Published on: September 10, 2021
Coronavirus Disease (COVID-19) and the Gastrointestinal System in Children
John Matthai1, Naresh Shanmugam2, Prasanth Sobhan3
1Masonic Medical Centre, Coimbatore, Tamil Nadu, India. Correspondence to: Prof John Matthai, Pediatric Gastroenterologist, Masonic Medical center, Race course, Coimbatore 641004, Tamil Nadu, India. psg_peds@yahoo.com.
Insights
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) can affect the gastrointestinal tract, with prolonged stool positivity suggesting fecal-oral transmission. Children with chronic liver disease or post-transplant should continue regular medication, while elective procedures are deferred.
Area of Science:
- Gastroenterology
- Virology
- Pediatrics
Background:
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) primarily affects the respiratory system but also impacts the gastrointestinal (GI) tract.
- Viral entry into GI tissues is facilitated by the co-expression of angiotensin-converting enzyme-2 (ACE-2) and transmembrane serine protease 2 (TMPRSS2) receptors.
- While less common, pediatric SARS-CoV2 infections can manifest with GI symptoms like diarrhea and vomiting.
Purpose of the Study:
- To investigate the gastrointestinal manifestations of SARS-CoV2 in children.
- To assess the risk of severe disease in pediatric patients with pre-existing liver conditions.
- To provide guidance on managing pediatric patients with GI involvement during the pandemic.
Main Methods:
- Review of clinical data and viral shedding in stool samples.
- Analysis of liver enzyme levels in infected children.
- Evaluation of outcomes in children with chronic liver disease and post-liver transplant status.
Main Results:
- Prolonged RT-PCR positivity in stool samples suggests potential fecal-oral transmission of SARS-CoV2.
- Elevated transaminases are frequently observed, particularly in severe cases of coronavirus disease (COVID-19).
- Children with inflammatory bowel disease and post-liver transplant recipients did not exhibit an increased risk for SARS-CoV2 disease.
Conclusions:
- SARS-CoV2 can cause gastrointestinal symptoms and prolonged fecal shedding in children.
- Children with chronic liver conditions should continue their prescribed medications.
- Elective procedures, such as endoscopy, should be postponed in pediatric patients during the pandemic to minimize exposure risks.
Abstract:
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), though primarily a respiratory pathogen, also involves the gastrointestinal tract. Similar to the respiratory mucosa, angiotensin converting enzyme-2 (ACE-2) receptor and transmembrane serine protease 2 (TMPRSS2) co-express in the gastrointestinal tract, which facilitates viral entry into the tissue. Less than 10% of children with infection develop diarrhea and vomiting. Prolonged RT PCR positivity in the stool has raised the possibility of feco-oral transmission. Elevated transaminases are common, especially in those with severe coronavirus disease (COVID-19). Children with inflammatory bowel disease and post liver transplant patients do not have an increased risk of disease, and should remain on medications they are already on. Children with chronic liver disease should continue their medications as usual. All elective procedures like endoscopy should be postponed.
Related Concept Videos
Gastrointestinal Motility Disorders
What is Monogastric Digestion?
Other Disorders of Digestive System
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Pathophysiology of Vomiting

